Cite
Markus R, Chow V, Pan Z, et al. Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men. Cancer Chemother Pharmacol. 2018;81(2):419doi: 10.1007/s00280-017-3457-8.
Markus, R., Chow, V., Pan, Z., & Hanes, V. (2018). Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men. Cancer chemotherapy and pharmacology, 81(2), 419. https://doi.org/10.1007/s00280-017-3457-8
Markus, Richard, et al. "Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men." Cancer chemotherapy and pharmacology vol. 81,2 (2018): 419. doi: https://doi.org/10.1007/s00280-017-3457-8
Markus R, Chow V, Pan Z, Hanes V. Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men. Cancer Chemother Pharmacol. 2018 Feb;81(2):419. doi: 10.1007/s00280-017-3457-8. PMID: 29159475; PMCID: PMC5778164.
Copy
Download .nbib